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INTRODUCTION
Salvia  is  an  important  genus  consisting  of  about 
900 species in the family Lamiaceae. Many species 
of Salvia, including Salvia officinalis L., have been 
used as traditional herbal medicine worldwide. In 
our  traditional  medicine,  sage  is  used  for  many 
ailments,  including  inflammation  of  the  mouth 
and throat (Tucakov, 1996). Extracts of different 
Salvia species have been examined for a number of 
biological activities so far, and their antimicrobial, 
anti-inflammatory, antioxidant, antimutagenic, can-
cer-preventive, spasmolytic, and cholinergic binding 
properties and involved mechanisms have been par-
tially described (Djarmati et al., 1991; Cuvelier 
et  al.,  1994;  Simić  et  al.,  1997;  Craig,  1999; 
Baricevic and Bartol, 2000; Mitić et al., 2001; 
Zupko et al., 2001; Capasso et al., 2004; Ren et 
al., 2004; Vujošević and Blagojević, 2004). It 
has even been reported that S. officinalis extracts are 
effective in the management of Alzheimer's disease 
(Akhondzadeh et al., 2003).
Tada et al. (1994) observed a potent antiviral 
activity against VSV (vesicular stomatitis virus) in 
crude extracts of S. officinalis and isolated the anti-
viral diterpenes safficinolid and sageon. Safficinolid 
caused  showed  reduction  of  VSV,  while  sageon 
exhibited virus inactivation activity against VSV and 
HSV-1 (herpes simplex virus type 1). Anti-HSV-1 
activity of methanol-water extracts of S. coccinia has 
also been reported (Rajbhandari et al., 2001). 
Sivropoulou et al. (1997) reported a virucidal 
effect  of  essential  oil  of  S.  fruticosa  and  its  main 
monoterpenoids -thujone, 1,8-cineole, and camphor 
- against HSV-1. All three compounds are usually 
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present in essential oils of S. officinalis (Wichtl, 
1994). In addition, the monoterpenoid isoborneol 
is a potent inhibitor of HSV-1 (khan et al., 2005). 
In  a  double-blind,  comparative,  randomized  trial, 
Saller et al. (2001) observed that a combined topi-
cal preparation with rhubarb and sage extracts was 
as effective as topical aciclovir cream in the treat-
ment of labial herpes.   
In the present study, we examined the cytotoxic-
ity and extracellular and intracellular antiviral activ-
ity  of  fractionated  extracts  of  wild  and  cultivated 
sage S. officinalis L. in vitro using the WISH-VSV 
model system. Extracts were obtained by fractionat-
ing depigmented ethanol extracts of sage plants with 
supercritical CO2 at different pressures. Supercritical 
CO2 extraction was used to allow isolation of higher 
terpenoids from wild and cultivated sage that were 
not known to be present in this plant (Djarmati 
et al., 1991, 1993, 1994).  
MATERIALS AND METHODS
Cell culture and viruses 
for detection of the antiviral and cytotoxic effect 
of extracts, we used WISH human amnion epithelial 
cells  (Cell Line Catalog, 5th Ed., 1997).  Cells  were 
cultivated  at  37°C  with  5%  CO2  in  Eagle's  MEM 
medium (Gibco) supplemented with 10% fetal calf 
serum (fCS), 100 i.u./ml penicillin, and 100 µg/ml 
streptomycin. The VSV (vesicular stomatitis virus) 
Indiana serotype was used to induce a cytopathic 
effect  (CPE).  Virus  dilutions  were  performed  in 
Eagle's MEM medium supplemented with 2% fCS.
Plant extracts
Plant extracts were obtained from R. M. Jankov, 
faculty of Chemistry, University of Belgrade. Two 
types of sage were extracted. Wild sage originated 
from  the  vicinity  of  Trpanj,  Pelješac  Peninsula, 
Dalmatia  (Croatia).  The  D-70  variety  of  sage, 
bred for cultivation in continental climates by the 
Institute for Hop, Sorghum, and Medicinal Plants, 
Bački  Petrovac,  Vojvodina  (Serbia)  was  grown  in 
the experimental field of the Institute. Plants were 
collected during the flowering period (May – June, 
1990) and the voucher specimens deposited in the 
herbarium of the Institute. 
The preparation of ethanol extracts and method 
of  CO2  reextraction  are  described  in  detail  by 
Djarmati et al. (1991, 1993, 1994). Briefly, dried 
aerial  parts  of  the  plants  were  subjected  to  three 
rounds  of  extraction  with  96%  ethanol,  and  the 
combined  filtrates  were  evaporated  to  about  10% 
dry matter. The resulting total extracts of wild sage 
(152),  cultivated  sage  (144),  and  steam-distilled 
cultivated sage (149) were passed through a column 
with active carbon to remove pigments and some 
polymerized  products,  and  fractionated  by  super-
critical CO2 extraction at different CO2 pressure for 
6 h. The 144 extract was fractionated at 60°C at 200, 
300, and 400 bars, and at 100°C at 500 bars, while 
the 152 and 149 extracts were fractionated at 60°C 
at  200  and  300  bars,  respectively.  fractions  were 
freeze-dried and stored at -20°C. The total yield of 
CO2 re-extracts obtained from dried plant material 
was 52.5 g (0.31%), 84.76 g (0.88%), and 110.48 g 
(1.175%) for the 152, 144, and 149 extracts, respec-
tively.
Sage extracts were first dissolved in 96% etha-
nol (1% of total volume) and then in Eagle's MEM 
medium  supplemented  with  antibiotics  and  2% 
fCS (up to 100% of total volume). The solution was 
cleared  by  three  rounds  of  centrifugation  at  3000 
rpm  for  10  minutes  before  two-fold  serial  dilu-
tions were made in Eagle's MEM medium. for each 
experiment, fresh extract solutions were made and 
tested for sterility. 
Cytotoxicity of sage extracts 
WISH cells (density 4x105 cells/well) were seeded 
in 96–well microtiter plates and cultivated for 24 h 
at 37°C in 5% CO2. Two-fold serial dilutions of plant 
extracts were added to the confluent cell monolayer 
and incubated for 24 h. After overnight incubation, 
cytotoxicity was determined by examining cellular 
morphology  in  situ  (freshney,  1983)  with  the 
aid of a colorimetric micromethod (Pestka et al., 
1981) and by cell staining with trypan blue (Doyle 
et al., 1995). Blue-stained cells were scored as non-
viable,  unstained  cells  as  viable.  The  maximum 
non-toxic concentration of the extract (CTD10) was ANTIVIRAL ACTIVITy Of SAlVIA oFFICInAlIS 423
defined as the concentration causing lethality of 10% 
of the cell population, i.e., resulting in cell survival of 
90% with no apparent changes in cell morphology.  
Antiviral activity
The antiviral effect of extracts was monitored 
through  reduction  of  the  cytopathic  effect  (CPE) 
caused by them in the VSV-WISH model system. 
A colorimetric micromethod and visual determina-
tion were used for detection of antiviral activity. As 
zero CPE, we adopted the color intensity of the cell 
culture control (cells + medium); 100% CPE was the 
color intensity of the virus infectivity control (cells 
+ virus). The value of CPE reduction was calculated 
as percent compared to the virus infectivity control. 
Controls of cell survival (cells + extract) were also 
included. Experiments were performed in the range 
of non-toxic concentrations of the extracts. 
The antiviral activity of plant extracts was quan-
titatively  expressed  as  the  selectivity  index  (IS), 
defined as the ratio of the maximum to minimum 
non-cytotoxic  concentrations  giving  100%  reduc-
tion of CPE. Extracts exhibit antiviral activity if IS≥2 
(Abou-karam and Shier, 1990). As a positive 
control of intracellular antiviral activity and a nega-
tive control of extracellular antiviral activity, we used 
human interferon-α (Torlak, Belgrade, Serbia).  
Antiviral effect at the extracellular level
A  high  concentration  of  virus  particles  (105 
TCID50/ml)  and  the  highest  non-toxic  concentra-
tion of extracts were mixed and incubated for 5 h at 
37°C in 5% CO2. At the end of the incubation peri-
od, a two-fold dilution of the virus-extract mixture 
was applied to the on cell monolayer. After incuba-
tion for 24-36 h at 37 °C in 5% CO2, the presence of 
100% CPE in virus infectivity control cultures was 
confirmed and the cultures fixed and stained.
Antiviral effect at the intracellular level
Two-fold serial dilutions of extracts were applied 
to confluent cell monolayers and incubated for 5 h 
at 37°C in 5% CO2. At the end of the incubation 
period, the extracts were removed, and the cultures 
were rinsed with PBS and infected with virus sus-
pensions (100 TCID50/ml). After incubation for 24-
36 h in 5% CO2, the presence of 100% CPE in virus 
infectivity control cultures was confirmed and the 
cultures fixed and stained. 
Antiviral effect on  the virus infective cycle
following penetration 
A virus suspension (100 TCID50/ml) was prein-
cubated with cell culture. After 90 min, cell cultures 
were rinsed with PBS and two-fold serial dilutions 
of  extracts  were  added  to  cell  monolayers.  After 
the incubation for 24-36 h at 37°C in 5% CO2, the 
presence of 100% CPE in virus infectivity control 
cultures was confirmed and the cultures fixed and 
stained.
RESULTS
The sage extracts used in this study were ethanol 
extracts  of  wild  (152)  and  cultivated  plants  (144) 
fractionated by supercritical CO2 at different pres-
sures (200, 300, 400, and 500 bars) to yield extracts 
designated  152/2,  144/2,  144/3,  144/4,  and  144/5. 
Extract 149/3, obtained from cultivated sage steam-
distilled  prior  to  ethanolic  extraction  to  remove 
volatile terpenoids, was also included in the study. 
The experiments were performed in 1994/95.
Cytotoxicity of sage extracts 
Examination of the cytotoxicity of sage extracts 
was performed in the range of concentrations up to 
10,000 µg/ml. The maximum non-cytotoxic concen-
trations (CTD10)  were read individually from the 
obtained survival curves.
According  to  the  results  of  this  experiment 
(Table 1), the fraction of wild sage obtained at 200 
bars (152/2) and fractions of cultivated sage obtained 
at 200, 300, and 400 bars (144/2, 144/3, and 144/4) 
had a similar range of cytotoxicity (CTD10 84-93 µg/
ml), while the fraction of cultivated sage obtained at 
500 bars (144/5) was non-toxic up to 199 µg/ml. The 
fraction of distilled sage obtained at 300 bars (149/3) 
was the most cytotoxic, with CTD10 of 44 µg/ml. 
Increased toxicity of all fractions was accompa-
nied by two types of changes in cell morphology. At 
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nuclei  were  more  prominent,  and  the  cells  were 
found to float in the medium. At higher concentra-
tions,  there  was  an    additional  type  of  change  in 
cell morphology, e.g., asteroid cells appeared which 
remained  adhered  to  the  substrate  and  were  not 
stained with trypan blue. With increase in concen-
trations of the extracts, the latter type of cells was 
more frequent; this gave U-shaped survival curves 
(not shown). Attempts to sub-cultivate asteroid cells 
failed, suggesting their physiological death.   
Extracellular antiviral effect of sage extracts 
The effect of sage extracts on viral infectivity was 
monitored in a direct preincubation test (Weber et 
al., 1992). As a negative control of extracellular anti-
viral activity, we used interferon-α (IfN-α), which 
is known to act at the intracellular level (Cantell 
and Strander, 1966). The results obtained in this 
test (100% CPE) showed that neither extracts nor 
IfN-α had any extracellular antiviral effect. 
Intracellular antiviral effect of sage extracts 
The antiviral assay was performed by incubating 
a WISH cell monolayer with non-toxic concentra-
tions of plant extracts for 5 h before viral infection. 
In this set of experiments, a positive control con-
sisted of IfN-α incubated with the WISH cell mono-
layer. The highest and the lowest concentrations of 
IfN-α which caused 100% reduction of CPE were 50 
and 25 i.u./ml, respectively (Table 2). Sage fractions 
144/2 and 149/3 had no intracellular antiviral effect, 
as CPE remained 100% at all tested concentrations 
(data  not  shown).  Although  sage  fractions  144/3, 
144/4, and 152/2 showed some reduction of CPE 
at sub-toxic concentrations, the obtained antiviral 
effect  was  not  considered  significant  (Table  2).  A 
clear  antiviral  effect  was  detected  with  fraction 
144/5 of cultivated sage. This fraction showed com-
plete inhibition of virus replication (100% reduction 
of  CPE) at  concentrations  of 99.5  and  199 µg/ml 
(Table 2), and the effect was comparable with the 
effect of IfN-α. To quantify the intracellular anti-
viral activity of 144/5, IS was calculated from the 
results presented in Table 2; the obtained value of 2 
confirmed antiviral activity of 144/5.
Effect of sage extracts on phases of the viral
infective cycle following penetration
Confluent  monolayer  cultures  of  WISH  cells 
were infected by VSV 90 min before the application 
of plant extracts. Many authors (Vanden Berge 
et  al.,  1986;  Zgorniak-Nowosielska  et  al., 
1989; Tommasi et al., 1991) consider 60-90 min 
of incubation sufficient for adsorption and penetra-
tion of the virus to occur. The reduction of CPE 
by  plant  extracts  in  this  experiment  reflects  their 
inhibitory effect on the phases of virus replication 
following penetration. Sage fractions 144/2, 149/3, 
Survival of cells (%)
fraction
(µg/ml)
152/2 144/2 144/3 144/4 144/5 149/3
    0 100 100 100 100 100 100
  19   99   99   98 100   98   97
  39   98   96   97   98   98   94
  78   92   93   94   95   94   52
156   80   50   25   72   92   15
315   28    6     3   26   85     1
625     7    4     0     1   52     7
CTD10   89  84   84    93 199   44
Data are the means of at least three independent experiments where cell survival was measured by selective staining with trypan blue. 
The same results (± 2%) were obtained from 10 colorimetric microtitrations. 
CTD10  values (concentrations which caused death the lethality of 10% of the cell population with no apparent changes in cell morphol-
ogy) were read individually from the obtained survival curves.
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Interferon – α
Concentr. (i.u./ml)     0  0.4  0.8  1.5  3.1  6.2  12.5  25.0  50.0
Reduction of CPE (%)    0  0  0  0  5  20  60  90  100
144/3
Concentr. (µg/ml) 0 0.6 1.3 2.6 5.2 10.5 21.0 42.0 84.0 µg/ml) 0 0.6 1.3 2.6 5.2 10.5 21.0 42.0 84.0 g/ml)     0  0.6  1.3  2.6  5.2  10.5  21.0  42.0  84.0
Reduction of CPE (%)    0  0  0  0  0  0  0  0  20
144/4
Concentr. (µg/ml) 0 0.7 1.4 2.9 5.8 11.6 23.2 46.5 93.0 µg/ml) 0 0.7 1.4 2.9 5.8 11.6 23.2 46.5 93.0 g/ml)     0  0.7  1.4  2.9  5.8  11.6  23.2  46.5  93.0
Reduction of CPE (%)    0  0  0  0  0  0  0  0  5
144/5
Concentr. (µg/ml) 0 1.5 3.1 6.2 12.4 24.8 48.7 99.5 199.0 µg/ml) 0 1.5 3.1 6.2 12.4 24.8 48.7 99.5 199.0 g/ml)     0  1.5  3.1  6.2  12.4  24.8  48.7  99.5  199.0
Reduction of CPE (%)    0  0  0  0  0  0  12  35  60
Data are the means of three independent experiments with 10 microtitrations.
Reduction of CPE (%) is calculated relative to virus infectivity control.
Table 3. Effect of sage extracts on phases of virus replication following penetration.
and  152/2  caused  no  reduction  of  CPE  at  any  of 
the  tested  concentrations  (data  not  shown),  indi-
cating no inhibitory potential on virus replication. 
The highest tested concentrations of sage fractions 
144/3 and 144/4 slightly suppressed virus replication 
(Table 3), but according to the criterion for antiviral 
activity, i.e., 80% reduction of CPE or plaque number 
(Abou-karam and Shier, 1990), they also have 
to  be  considered  as  having  no  antiviral  potential. 
fraction 144/5 at concentrations 49.7, 99.5, and 199 
µg/ml showed reduction of CPE by 12, 35 and 60%, 
respectively (Table 3). In this experiment, 144/5 was 
less efficient in inhibition of VSV replication than 
IfN-α (90 and 100% reduction of CPE at concentra-
tions of 25 and 50 i.u./ml, respectively, Table 3).
DISCUSSION AND CONCLUSIONS
According to Vanden Berghe et al., (1986), 
when screening plant extracts for antiviral activity in 
vitro one is looking for non-specific action of antivi-
Interferon – α 
Concentr. (i.u./ml)     0  0.4  0.8  1.5  3.1  6.2  12.5  25.0  50.0
Reduction of CPE (%)    0  0  0  0  10  35  70  100  100
152/2
Concentr. (µg/ml) 0 0.7 1.4 2.8 5.5 11.1 22.2 44.5 89.0 µg/ml) 0 0.7 1.4 2.8 5.5 11.1 22.2 44.5 89.0 g/ml)     0  0.7  1.4  2.8  5.5  11.1  22.2  44.5  89.0
Reduction of CPE (%)    0  0  0  0  0  0  5  10  10
144/3
Concentr. (µg/ml) 0 0.6 1.3 2.6 5.2 10.5 21.0 42.0 84.0 µg/ml) 0 0.6 1.3 2.6 5.2 10.5 21.0 42.0 84.0 g/ml)     0  0.6  1.3  2.6  5.2  10.5  21.0  42.0  84.0
Reduction of CPE (%)    0  0  0  0  0  0  0  10  75
144/4
Concentr. (µg/ml) 0 0.7 1.4 2.9 5.8 11.6 23.2 46.5 93.0 µg/ml) 0 0.7 1.4 2.9 5.8 11.6 23.2 46.5 93.0 g/ml)     0  0.7  1.4  2.9  5.8  11.6  23.2  46.5  93.0
Reduction of CPE (%)    0  0  0  0  0  0  0  5  30
144/5
Concentr. (µg/ml) 0 1.5 3.1 6.2 12.4 24.8 48.7 99.5 199.0 µg/ml) 0 1.5 3.1 6.2 12.4 24.8 48.7 99.5 199.0 g/ml)     0  1.5  3.1  6.2  12.4  24.8  48.7  99.5  199.0
Reduction of CPE (%)    0  0  0  0  0  5  60  100  100
Data are the means of three independent experiments with 10 microtitrations.
Reduction of CPE (%) is calculated relative to virus infectivity control.
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ral agents on infected cells. Antiviral effects such as 
a lower virus titer may result from virucidal action 
and/or non-specific effects on cells that limit viral 
infection. However, by varying experimental condi-
tions, we can address questions concerning direct 
extracellular effects on virus particles, i.e., whether 
they involve chemical or physical damage to viruses 
resulting  in  the  prevention  of  virus  adsorption 
(Sydiskis  et  al.,  1991)  or  direct  intracellular 
(reversible or irreversible) selective action on some 
steps in virus biosynthesis (Leary et al., 2002).
In  this  study,  we  evaluated  cytotoxicity  and 
extracellular  and  intracellular  antiviral  activity  of 
fractionated extracts of wild and cultivated sage con-
taining terpenoids in the WISH-VSV model system. 
Common terpenoids in both plants are viridiflorol 
(a  sesquiterpenoid)  and  the  diterpenoids  manool 
and  rosmanol  9-ethyl  ether.  The  diterpenoid  12-
deoxo-carnosol is present only in wild sage, while 
the  diterpenoids  galdosol,  carnosic  acid  6-methyl 
ether, carnosic acid 6-methyl ether-γ-lactone, and 
triterpenoid oleanic acid are present only in culti-
vated sage. fractions contain different proportions 
of terpenoids: manool and viridiflorol are predomi-
nant  in  the  fractions  obtained  at  200  bars  (152/2 
and 144/2), carnosic acid 6-methyl ether and car-
nosic acid 6-methyl ether-γ-lactone in the fractions 
obtained at 300 bars (149/3 and 144/3), and oleanic 
acid in the fraction obtained at 500 bars (144/5). In 
addition, extracts 152 and 144 contain monoterpe-
noids from essential oils (Djarmati et al., 1993; 
1994; Djordjević, 1994).
The  results  obtained  in  investigation  of  cyto-
toxicity  showed  that  the  cytotoxicity  of  extracts 
depended  on  the  plant  used  and  the  method  of 
extraction applied. The most toxic extract was 149/3 
from distilled cultivated sage, indicating that higher 
terpenoids are cytotoxic principals of this extract. 
149/3 contains a larger proportion of higher terpe-
noids than 144/3 obtained from non-distilled culti-
vated sage at the same CO2 pressure (Djordjević, 
1994),  among  which  galdosol,  rosmanol  9-ethyl 
ether, and carnosic acid were reported to have high 
cytostatic activity (Hayashi et al., 1987; Darias 
et al., 1990; Steiner et al., 2001). 
It is interesting that all tested extracts induced 
two types of changes in cell morphology at cytotoxic 
concentrations. At concentrations up to 625 µg/ml, 
only  spheroid  cells  floating  in  the  medium  were 
observed, indicating necrosis, but higher concentra-
tions induced an increasing number of cells whose 
morphology was similar to apoptotic cells within the 
limits of optical microscopy (Doyle et al., 1995). 
This  observation  deserves  further  study  because 
apoptosis-inducing  plant  extracts  are  potentially 
useful in chemoprevention.
Evaluation  of  extracellular  antiviral  activity 
showed  that  preincubation  of  VSV  particles  with 
extracts did not arrest their infectivity, suggesting 
that none of the extracts caused physical or chemical 
changes of the virions. Our results differ from the 
results of Sivropoulou et al. (1997), who found 
that  the  monoterpenoids  thujone  and  camphor 
(present in extracts 152 and 144) are virucidal to 
HSV-1. Many reports indicate that antiviral agents 
possess  different  activity  against  different  viruses 
(Zgorniak-Nowosielska et al., 1989; Weber 
et al., 1991; Shih-Bin et al., 2001; Leary et al., 
2002).
The  results  of  investigating  the  intracellular 
antiviral activity of sage extracts showed that sage 
fractions 144/2 and 149/3 did not reduce the CPE 
of  VSV  in  the  range  of  non-toxic  concentrations. 
Although  fractions  of  cultivated  and  wild  sage 
144/3, 144/4, and 152/2 at sub-toxic concentrations 
did show some reduction of the CPE of VSV in cell 
culture, meaning that they probably inhibit to some 
extent virus multiplication at intracellular level, this 
reduction  was  not  sufficient  to  pronounce  frac-
tions 144/3, 144/4, and 152/2 antiviral. According 
to  the  classification  of  antiviral  agents  (Vanden 
Berghe et. al., 1986; Abou-karam and Shier, 
1990), antiviral activity exists if 100% reduction of 
CPE is observed at subsequent two-fold dilutions in 
the range of non-toxic concentrations of the extract. 
The reduction of CPE caused by 144/3, 144/4, and 
152/2 at the highest tested concentrations was less 
than 100%, and at two-fold lower concentrations it 
was only about 10%. 
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reduction of CPE, both at the highest non-toxic con-
centration and at the next two-fold dilution. Since 
the number of infecting viral particles was constant, 
this  indicates  stable  antiviral  activity.  Less  than 
100% reduction of CPE was also detected in the two 
next  two-fold  dilutions.  The  selectivity  index  (IS) 
was 2, which indicates minimal antiviral activity in 
the WISH-VSV model system. 
Investigation  of  the  antiviral  effect  of  sage 
extracts against phases of virus replication follow-
ing penetration confirmed that sage fractions 144/2, 
149/3, and 152/2 had no antiviral potential, while 
fractions 144/3 and 144/4 disturbed virus replica-
tion to a slight extent (20 and 5% inhibition of CPE). 
Extract 144/5 at the maximum non-toxic concentra-
tion reduced CPE by 60%, indicating some inhibi-
tion of virus replication. However, the absence of 
100% reduction of CPE at non-toxic concentrations 
indicates that the effect of extract 144/5 is not stable 
and selective for phases of virus replication follow-
ing  penetration.  Comparing  the  antiviral  activity 
of IfN-α and fraction 144/5, we can conclude that 
extract 144/5 possessed antiviral activity similar to 
that of interferon at the intracellular level. However, 
due to weaker activity of 144/5 in comparison with 
interferon against virus replication following pen-
etration, we can only speculate about the "interferon 
- like" activity of 144/5. 
Taken  together,  the  obtained  results  indicate 
that the mechanism of antiviral activity of extract 
144/5 involves inhibition of the early steps of the 
virus infective cycle without a direct virucidal effect. 
This mechanism has been proposed for the antiviral 
effect  of  Spirulina  maxima  extract  against  HSV-
2  (herpes  simplex  virus  type  2)  (Hernandez-
Corona et al., 2002). The reduction of CPE by 
144/5  after  adsorption  and  penetration  of  VSV 
had occurred probably involved some non-specific 
action on host cells affecting virus biosynthesis and 
limiting viral infection. At the moment we can only 
speculate  that  triterpenoid  oleanic  acid,  which  is 
predominant in 144/5, might be responsible for the 
antiviral activity of this fraction. Antiviral activity 
of triterpenoids such as maslinic and ursolic acid 
against many viruses has been reported (Jassim 
and Naji, 2003). 
Study of the antiviral effects of plant extracts is 
aimed at developing new strategies in the treatment 
of different viral infections. Many traditional medic-
inal  plants  have  been  reported  to  possess  strong 
antiviral  activity,  and  some  of  them  have  already 
been used to treat animals and people against dif-
ferent viral infections (Jassim and Naji, 2003). 
from our results with sage it is clear that cultivated 
sage,  especially  fraction  144/5,  deserves  further 
investigation to evaluate its antiviral potential and 
active principals against different viruses. Regardless 
of  negative  results  obtained  in  the  WISH-VSV 
model system, it is still of interest to investigate the 
antiviral effect of cultivated sage in other model sys-
tems. This is especially true for fractions 144/3 and 
144/4, because in our study the reduction of CPE 
was above zero. The possibility of cultivating sage 
variety D-70 on an industrial scale and obtaining 
large  quantities  of  CO2  fractions  should  facilitate 
these investigations and lead to future application of 
antivirals from this plant.
In conclusion, the terpenoid fraction of the D-70 
variety of cultivated sage, obtained at CO2 pressure 
of 500 bars and temperature of 100°C was the least 
toxic to WISH cells. It also showed the lowest anti-
viral  activity  against  the  VSV  virus.  The  antiviral 
activity of this fraction is intracellular, stable, and 
more pronounced against the whole VSV infective 
cycle than at the phases of virus replication follow-
ing penetration.    
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у раду је исﾭпитивана антивиралﾭна акﾭтивносﾭт 
разﾭлﾭичито фракﾭционисﾭаних екﾭсﾭтракﾭата дивље и 
гајене  жалﾭфије  Salvia  officinalis  L.  (Lamiaceae)  у 
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и  бојењем  ћелﾭија  сﾭа  трипан  плﾭавим.  фракﾭција 
гајене жалﾭфије добијена на CO2 притисﾭкﾭу од 300 
бара и температури од 60°C (149/3) је покﾭазﾭалﾭа 
највећу цитотокﾭсﾭичносﾭт (CTD10 44 µg/ml). фракﾭ-
ција не-десﾭтилﾭисﾭане гајене жалﾭфије добијена на 
CO2 притисﾭкﾭу од 500 бара и температури од 100°C 
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антивиралﾭни ефекﾭат на интрацелﾭулﾭарном нивоу: 
кﾭада сﾭе ћелﾭије третирају 5 сﾭати пре VSV инфекﾭци-
је, редукﾭција CPE је билﾭа 100% на кﾭонцентрацији 
од  99.5  и  199.0  µg/ml;  кﾭада  сﾭе  ћелﾭије  третирају 
посﾭлﾭе улﾭасﾭкﾭа вирусﾭа у ћелﾭију на исﾭтим кﾭонцентар-
цијама редукﾭција CPE изﾭносﾭи 35% односﾭно 60%. 
Добијени  резﾭулﾭтати  укﾭазﾭују  да  фракﾭција  144/5 
има антивиралﾭну акﾭтивносﾭт кﾭоја сﾭе осﾭтварује кﾭрозﾭ 
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